ODDITY Tech (NASDAQ: ODD) reports ODDITY LABS CSO departure in SEC filing

Rhea-AI Filing Summary

ODDITY Tech Ltd. filed a Form 6-K to report that Dr. Ido Bachelet, formerly the Chief Science Officer of ODDITY LABS, is no longer employed by the company. His responsibilities have been taken over by other members of the ODDITY LABS leadership team. The company states that his departure did not arise from any disagreement about its operations, policies, or practices, and that this organizational change is not expected to affect ODDITY LABS’ financial outlook, day-to-day operations, or the product development and commercialization timelines of ongoing projects. The report is also incorporated by reference into ODDITY Tech’s existing Form S-8 registration statement.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange

Act of 1934

For the month of January 2026

Commission File Number: 001-41745

ODDITY Tech Ltd.

(Translation of registrant’s name into English)

8 HaHarash Street,

Tel Aviv-Jaffa, 6761304, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-Fx    Form 40-F ¨

Other Events

ODDITY Tech Ltd. (the “Company”) today announces that Dr. Ido Bachelet is no longer employed with the Company. Dr. Bachelet formerly served as the Chief Science Officer of ODDITY LABS. His responsibilities have been assumed by other members of the ODDITY LABS leadership team. His departure is not the result of any disagreement regarding the Company’s operations, policies, or practices. This organizational change is not expected to impact the Company’s financial outlook or operations of ODDITY LABS, including the product development or commercialization timelines of any ongoing projects.

This Report on Form 6-K shall be deemed to be incorporated by reference into the Company’s registration statement on Form S-8 (Registration No. 333-274796) filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ODDITY TECH LTD.
	By:	/s/ Lindsay Drucker Mann
		Name: Lindsay Drucker Mann
		Title: Global Chief Financial Officer

Date: January 7, 2026

FAQ

What leadership change did ODDITY Tech (ODD) disclose in this Form 6-K?

ODDITY Tech disclosed that Dr. Ido Bachelet, formerly Chief Science Officer of ODDITY LABS, is no longer employed with the company, and his duties have been assumed by other ODDITY LABS leaders.

Did ODDITY Tech (ODD) report any disagreement related to Dr. Bachelet’s departure?

The company stated that Dr. Bachelet’s departure was not the result of any disagreement regarding ODDITY Tech’s operations, policies, or practices.

How does Dr. Bachelet’s departure affect ODDITY LABS’ financial outlook and operations?

ODDITY Tech stated that this organizational change is not expected to impact the financial outlook or operations of ODDITY LABS, including product development or commercialization timelines.

Who will handle the responsibilities of the former ODDITY LABS Chief Science Officer?

The filing explains that Dr. Bachelet’s responsibilities have been assumed by other members of the ODDITY LABS leadership team.

How is this Form 6-K used in ODDITY Tech’s existing SEC registrations?

The report is deemed incorporated by reference into ODDITY Tech’s Form S-8 registration statement (Registration No. 333-274796) from the date it is filed, unless later superseded.

Does this Form 6-K from ODDITY Tech include any financial results?

No, this Form 6-K focuses on an organizational change at ODDITY LABS and does not present financial results or earnings data.